Atomoxetine in <font color="red">autism_4</font> <font color="red">spectrum_4</font> <font color="red">disorder_4</font> <font color="red">:_4</font> no effects on social functioning ; some beneficial effects on stereotyped behaviors , inappropriate speech , and fear of change . 
<br>
<br> UNLABELLED Abstract Objective : The objective of this study was to investigate the <font color="red">short_1</font> <font color="red">-_1</font> <font color="red">term_1</font> <font color="red">treatment_1</font> <font color="red">effects_1</font> <font color="red">of_1</font> <font color="red">atomoxetine_1</font> <font color="red">on_1</font> <font color="red">autism_2</font> <font color="red">spectrum_2</font> <font color="red">disorder_2</font> <font color="red">(_2</font> <font color="red">ASD_2</font> <font color="red">)_2</font> <font color="red">symptoms_2</font> <font color="red">in_2</font> <font color="red">children_6</font> <font color="red">and_6</font> <font color="red">adolescents_6</font> <font color="red">with_6</font> <font color="red">both_6</font> <font color="red">ASD_6</font> <font color="red">and_6</font> <font color="red">attention_6</font> <font color="red">-_6</font> <font color="red">deficit_6</font> <font color="red">/_6</font> <font color="red">hyperactivity_6</font> <font color="red">disorder_6</font> <font color="red">(_6</font> <font color="red">ADHD_6</font> <font color="red">)_6</font> <font color="red">._6</font> <font color="red">
<br>_1</font> METHODS <font color="red">A_3</font> <font color="red">total_3</font> <font color="red">of_3</font> <font color="red">97_7</font> <font color="red">patients_7</font> <font color="red">6_7</font> <font color="red">-_7</font> <font color="red">17_7</font> <font color="red">years_7</font> <font color="red">of_7</font> <font color="red">age_7</font> <font color="red">,_7</font> <font color="red">with_7</font> <font color="red">ASD_7</font> <font color="red">and_7</font> <font color="red">ADHD_7</font> <font color="red">,_7</font> were treated with 1.2 â€‰ mg / kg / day of atomoxetine during an 8 week double - blind placebo - controlled period . Here , we investigated effects on two parent - based secondary outcome measures , the Aberrant Behavior Checklist ( ABC ) and the Children 's Social Behavior Questionnaire ( CSBQ ) . 
<br> RESULTS After 8 weeks of double - blind treatment , atomoxetine administration was associated with significant treatment effects on the ABC subscales Hyperactivity , Inappropriate Speech , and Stereotypic Behavior , and on the CSBQ subscale Fear for Changes . 
<br> CONCLUSIONS Our study results indicate no beneficial effects of atomoxetine on social functioning . However , atomoxetine may ameliorate restricted and stereotyped behaviors and communication . This study has been registered in ClinicalTrials.gov ( www.clinicaltrials.gov ) under registration number NCT00380692 .